NCT01159483View on ClinicalTrials.gov

First-in-Human Study of PF-04958242 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 15, 2010

Primary Completion Date

October 16, 2010

Study Completion Date

October 16, 2010

Conditions
Healthy Volunteer
Interventions
DRUG

PF-04958242

Administered as specified in the treatment arm

DRUG

Placebo

Administered as specified in the treatment arm

Trial Locations (1)

188770

Research Site, Singapore

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY